Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
confident statements are premature
NNMT acts as a primary metabolic gatekeeper, predominantly active in fat tissue and liver cells, where it methylates nicotinamide (NAM) using S-adenosyl-L-methionine (SAM) as a methyl donor
This product is not intended to diagnose, treat, cure, or prevent any disease, and individual results may vary
Weight loss accelerates
The only clinical data originate from a week-long trial where participants received approximately 0.03mg of ipamorelin per kilogram of body weight twice daily
Important Notes These are the points most often dropped when AHK-Cu is marketed as an injectable hair-growth peptide. No human trial exists state it plainly: there is no clinical trial of AHK-Cu by any route, and the entire peptide-specific peer-reviewed base is one 2007 study that was ex vivo and in vitro [1]
